SCHEMBL2014534

SCHEMBL2014534

CN(C(=O)c1ccc2ncoc2c1)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.66
HCRTR2 O43614 2/20 0.66
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
CYP3A4 P08684 1/20 0.39
TP53 P04637 3/20 0.38
LMNA P02545 1/20 0.36
HRH3 Q9Y5N1 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
PADI4 Q9UM07 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2010859 0.94 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9ATP53
SCHEMBL2015950 0.87 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2013242 0.87 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2013232 0.86 HCRTR1 (0.63) HCRTR1HCRTR2NPC1RAB9ATAS1R3
SCHEMBL2015002 0.86 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9ATP53
SCHEMBL2010631 0.85 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9ATP53
SCHEMBL2013785 0.85 HCRTR1 (0.67) HCRTR1HCRTR2NPC1RAB9ALMNA
SCHEMBL2013098 0.84 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2017565 0.84 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9ATAS1R3
SCHEMBL2015169 0.84 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9AHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed